Also found in: Medical.
HSCTHematopoietic Stem Cell Transplant
HSCTHealth and Social Care Trust (UK)
HSCTHigh Speed Civil Transport
HSCTHigh School Competency Test
HSCTHypersonic Commercial Transport
HSCTHygiène Sécurité Conditions de Travail en Collectivité Territoriale
HSCTHayling Sentence Completion Task
HSCTHudson County Schools of Technology (North Bergen, NJ)
HSCTHygiène, Sécurité et Condition de Travail (French: Health, Safety and Working Conditions)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
In a prospective study conducted by Morito et al., urinary alpha 1M was found to be useful for predicting severe AKI after HSCT [86].
Methods: rFVIIa was given as a single dose of 60ug/kg in patients with GI bleeding following hematopoietic stem cell transplantation (HSCT).
This study investigated demographic and socioeconomic factors that may account for the low use of HSCT to treat these hematologic malignancies.
Adriana Bastidas, M.D., from GlaxoSmithKline in Wavre, Belgium, and colleagues examined the efficacy and adverse event profile of recombinant zoster vaccine in immunocompromised autologous HSCT recipients in a phase 3 trial.
The observed incidence of BK virus-associated HC is 8%-25% and 7%-54% in pediatric and adult patients, respectively, and is higher after allogeneic HSCT than after autologous HSCT, particularly after haploidentical HSCT with post-transplant exposure to cyclophosphamide as prophylaxis for graft versus host disease.
During the pre-engraftment period (i.e., the first 2 weeks after HSCT), the most relevant causes of nausea and vomiting are the chemotherapeutic agents used in conditioning regimens, with or without body irradiation.
HSCT is an intravenous infusion of bone marrow cells to patients with a variety of acquired and inherited malignant and non-malignant disorders including blood cancer, sickle cell disease and thalassaemia.
T lymphocyte ablation and immunosuppressive therapy for the HSCT recipient induces a loss of CMV-specific immunity.
Allogeneic HSCT (allo-HSCT) has a curative potential for patients with PTCLs, which is partly mediated by graft versus lymphoma (GVL) effects.
Although serologic screening of HSCT donors is not mandatory, all responding countries reported that they were performing this screening.
So Haploidentical HSCT is the only ray of hope in the presence of above mentioned constraints and limitations.
Taking to Google one night, she entered the desperate question, "Is there a cure for MS?", which led her to a series of blogs run by other sufferers, before she found a doctor in Moscow offering HSCT. So she signed up.